| Literature DB >> 34772897 |
Brandon J Rea1, Abigail Davison1, Martin-Junior Ketcha1, Kylie J Smith1, Aaron M Fairbanks1, Anne-Sophie Wattiez1,2, Pieter Poolman2,3,4, Randy H Kardon2,3,4, Andrew F Russo1,2,5, Levi P Sowers1,2.
Abstract
ABSTRACT: We developed an automated squint assay using both black C57BL/6J and white CD1 mice to measure the interpalpebral fissure area between the upper and lower eyelids as an objective quantification of pain. The automated software detected a squint response to the commonly used nociceptive stimulus formalin in C57BL/6J mice. After this validation, we used the automated assay to detect a dose-dependent squint response to a migraine trigger, the neuropeptide calcitonin gene-related peptide, including a response in female mice at a dose below detection by the manual grimace scale. Finally, we found that the calcitonin gene-related peptide amylin induced squinting behavior in female mice, but not males. These data demonstrate that an automated squint assay can be used as an objective, real-time, continuous-scale measure of pain that provides higher precision and real-time analysis compared with manual grimace assessments.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34772897 PMCID: PMC9085964 DOI: 10.1097/j.pain.0000000000002537
Source DB: PubMed Journal: Pain ISSN: 0304-3959 Impact factor: 7.926